Programmed Death-1/Programmed Death-Ligand 1-Axis Blockade in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Stratified by Human Papillomavirus Status: A Systematic Review and Meta-Analysis

BACKGROUND: Programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) inhibitors have provided clinical benefit to head and neck squamous cell carcinoma (HNSCC) patients in recent clinical trials. However, it remains unclear as to whether human papillomavirus (HPV) status is associated with improved...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yimin, Zhu, Gangcai, Maroun, Christopher A., Wu, Irene X. Y., Huang, Donghai, Seiwert, Tanguy Y., Liu, Yong, Mandal, Rajarsi, Zhang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058384/
https://www.ncbi.nlm.nih.gov/pubmed/33897693
http://dx.doi.org/10.3389/fimmu.2021.645170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8058384/
https://www.ncbi.nlm.nih.gov/pubmed/33897693
http://dx.doi.org/10.3389/fimmu.2021.645170

Ejemplares similares